A
Alessandro Serretti
Researcher at University of Bologna
Publications - 817
Citations - 35088
Alessandro Serretti is an academic researcher from University of Bologna. The author has contributed to research in topics: Bipolar disorder & Major depressive disorder. The author has an hindex of 81, co-authored 711 publications receiving 30197 citations. Previous affiliations of Alessandro Serretti include University of Sassari & Vita-Salute San Raffaele University.
Papers
More filters
Book ChapterDOI
Pharmacogenetics of the Efficacy and Side Effects of Antidepressant Drugs
TL;DR: The pharmacogenetics of antidepressants has developed since the 1990s as a promising tool to produce tailored treatments of MDD as an established evidence of being significantly affected by genetic polymorphisms.
Journal ArticleDOI
Persistent benefits of slow titration of paroxetine in a six-month follow-up.
TL;DR: The current study extends to 6 months the previously published report in which paroxetine was started at 2.5 mg/day and slowly increased or rapidly titrated to target dose from 10 mg/day in a naturalistic setting.
Book ChapterDOI
Gene-Environment Interaction Studies in Suicidal Behaviour
TL;DR: In this paper, Gene-environment interaction (G × E) studies may be useful for elucidating the role of genetic and environmental risk factors in suicidal behavior, which is supported by increasing evidence.
Journal ArticleDOI
Machine Learning Prediction of Comorbid Substance Use Disorders among People with Bipolar Disorder
Vincenzo Oliva,M. De Prisco,M. Pons-Cabrera,P. Guzmán,Gerard Anmella,Diego Hidalgo-Mazzei,Iria Grande,Giuseppe Fanelli,Chiara Fabbri,Alessandro Serretti,Michele Fornaro,Felice Iasevoli,Andrea de Bartolomeis,Andrea Murru,Eduard Vieta,Giovanna Fico +15 more
TL;DR: In this paper , the authors identified the factors associated with different types of substance use disorder (SUD) in individuals with bipolar disorder (BD) through machine-learning models, and trained a Random Forest (RF) model to identify the presence of (i) any SUD in the total sample, (ii) alcohol use disorder and (iii) AUD co-occurrence with at least another SUD among patients with SUD.
Journal ArticleDOI
Imputed expression of schizophrenia‐associated genes and cognitive measures in patients with schizophrenia
TL;DR: Cognitive dysfunction is a core manifestation of schizophrenia and one of the best predictors of long‐term disability and genes increasing risk for schizophrenia may partly act through the modulation of cognition.